Result 1 - 10 of total 28
Alex. J. Med.
| Keywords | covid19 |
|---|---|
| Publisher | WHO |
| Document type | Article |
| Note | WHO #Covidence: #706317 |
| Database | COVID19 |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
Alexandria Journal of Medicine
2020 Volume 56, Issue 1, Page(s) 132–133
| Keywords | covid19 |
|---|---|
| Language | English |
| Publisher | Informa UK Limited |
| Publishing country | uk |
| Document type | Article ; Online |
| ZDB-ID | 2631785-0 |
| ISSN | 2090-5068 |
| ISSN | 2090-5068 |
| DOI | 10.1080/20905068.2020.1785144 |
| Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of pharmacy & bioallied sciences
2023 Volume 15, Issue 1, Page(s) 49–56
Abstract: Background: Diabetes mellitus (DM) is a chronic disease associated with a major economic burden on persons, health care systems, and countries. Diabetes self-management education and support (DSME(S)) programs are highly effective method in the ... ...
| Abstract | Background: Diabetes mellitus (DM) is a chronic disease associated with a major economic burden on persons, health care systems, and countries. Diabetes self-management education and support (DSME(S)) programs are highly effective method in the management of T2DM patients. Therefore, this study aimed to determine the cost-effectiveness of the developed culturally-specific DSME(S) program regarding glycemic control, lipid profile, and body weight for Iraqi type 2 DM patients. Methods: A randomized controlled clinical trial design was used to assess the cost-effectiveness of the culturally-specific DSME(S) program from the perspective of health care providers. In the cost-effectiveness analysis (CEA), cost per patient and clinical outcomes over 6 months were compared between the intervention and control group. Incremental cost-effectiveness ratios (ICERs) were expressed as cost per unit improvement in glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP), and body weight. Results: The effectiveness of most outcomes was better in the intervention group compared with the control group. The ICER per unit improvement in HbA1c, SBP, DBP, serum TC, and TG levels was <1 of the minimum CET compared with the control group, thus meeting the definition of being highly cost-effective. Conclusion: The currently developed DSME(S) was cost effective method to improve glycemic control, blood pressure, TC, and TG for T2DM patients in Iraq. |
|---|---|
| Language | English |
| Publishing date | 2023-04-14 |
| Publishing country | India |
| Document type | Journal Article |
| ZDB-ID | 2573569-X |
| ISSN | 0975-7406 ; 0976-4879 |
| ISSN (online) | 0975-7406 |
| ISSN | 0976-4879 |
| DOI | 10.4103/jpbs.jpbs_767_21 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of Pharmacy and Bioallied Sciences, Vol 15, Iss 1, Pp 49-
2023 Volume 56
Abstract: Background: Diabetes mellitus (DM) is a chronic disease associated with a major economic burden on persons, health care systems, and countries. Diabetes self-management education and support (DSME(S)) programs are highly effective method in the ... ...
| Abstract | Background: Diabetes mellitus (DM) is a chronic disease associated with a major economic burden on persons, health care systems, and countries. Diabetes self-management education and support (DSME(S)) programs are highly effective method in the management of T2DM patients. Therefore, this study aimed to determine the cost-effectiveness of the developed culturally-specific DSME(S) program regarding glycemic control, lipid profile, and body weight for Iraqi type 2 DM patients. Methods: A randomized controlled clinical trial design was used to assess the cost-effectiveness of the culturally-specific DSME(S) program from the perspective of health care providers. In the cost-effectiveness analysis (CEA), cost per patient and clinical outcomes over 6 months were compared between the intervention and control group. Incremental cost-effectiveness ratios (ICERs) were expressed as cost per unit improvement in glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP), and body weight. Results: The effectiveness of most outcomes was better in the intervention group compared with the control group. The ICER per unit improvement in HbA1c, SBP, DBP, serum TC, and TG levels was <1 of the minimum CET compared with the control group, thus meeting the definition of being highly cost-effective. Conclusion: The currently developed DSME(S) was cost effective method to improve glycemic control, blood pressure, TC, and TG for T2DM patients in Iraq. |
|---|---|
| Keywords | cost-effectiveness ; diabetes self-management education and support ; iraq ; type 2 diabetes mellitus ; Pharmacy and materia medica ; RS1-441 ; Analytical chemistry ; QD71-142 |
| Subject code | 796 |
| Language | English |
| Publishing date | 2023-01-01T00:00:00Z |
| Publisher | Wolters Kluwer Medknow Publications |
| Document type | Article ; Online |
| Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
2022 Volume 36, Issue 4, Page(s) 980–987
Abstract: ... ...
| Abstract | Background |
|---|---|
| MeSH term(s) | Humans ; Sitagliptin Phosphate/adverse effects ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Diabetes Mellitus, Type 2/drug therapy ; COVID-19 ; Treatment Outcome |
| Chemical Substances | Sitagliptin Phosphate (TS63EW8X6F) ; Dipeptidyl-Peptidase IV Inhibitors |
| Language | English |
| Publishing date | 2022-05-17 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 1027474-1 |
| ISSN | 1531-1937 ; 0897-1900 |
| ISSN (online) | 1531-1937 |
| ISSN | 0897-1900 |
| DOI | 10.1177/08971900221102119 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 2893: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2016 Volume 2016, Page(s) 6962574
Abstract: Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a serious risk that faces diabetic patients who fast during Ramadan (the 9th month in the Islamic calendar). New glucose-lowering classes like dipeptidyl ... ...
| Abstract | Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a serious risk that faces diabetic patients who fast during Ramadan (the 9th month in the Islamic calendar). New glucose-lowering classes like dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide 1 receptor agonist (GLP-1 RA), and sodium-glucose cotransporter-2 (SGLT-2) inhibitors are efficacious in controlling blood glucose level with less tendency to induce hypoglycemia and thus may constitute a good choice for diabetic patients during Ramadan. This study reviews the safety and efficacy of newer glucose-lowering therapies during Ramadan. This study was accomplished through a careful literature search about studies that assess the benefit and side effects of these new glucose-lowering therapies during Ramadan during September 2015. Vildagliptin, sitagliptin, liraglutide, exenatide, and dapagliflozin were the only studied glucose-lowering therapies. All of the studied newer glucose-lowering therapies except dapagliflozin were associated with reduced risk to induce hypoglycemia. Gastrointestinal upset was common with the usage of liraglutide while increased thirst sensation was common with dapagliflozin. In conclusion DPP-4 inhibitors such as vildagliptin and sitagliptin may form a suitable glucose-lowering therapy option for Ramadan fasting patients. |
|---|---|
| MeSH term(s) | Adamantane/adverse effects ; Adamantane/analogs & derivatives ; Adamantane/therapeutic use ; Benzhydryl Compounds/adverse effects ; Benzhydryl Compounds/therapeutic use ; Diabetes Mellitus, Type 2/drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Exenatide ; Fasting ; Glucagon-Like Peptide-1 Receptor/agonists ; Glucosides/adverse effects ; Glucosides/therapeutic use ; Holidays ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Islam ; Liraglutide/adverse effects ; Liraglutide/therapeutic use ; Nitriles/adverse effects ; Nitriles/therapeutic use ; Peptides/adverse effects ; Peptides/therapeutic use ; Pyrrolidines/adverse effects ; Pyrrolidines/therapeutic use ; Sitagliptin Phosphate/adverse effects ; Sitagliptin Phosphate/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors ; Venoms/adverse effects ; Venoms/therapeutic use ; Vildagliptin |
| Chemical Substances | Benzhydryl Compounds ; Dipeptidyl-Peptidase IV Inhibitors ; Glucagon-Like Peptide-1 Receptor ; Glucosides ; Hypoglycemic Agents ; Nitriles ; Peptides ; Pyrrolidines ; Sodium-Glucose Transporter 2 Inhibitors ; Venoms ; dapagliflozin (1ULL0QJ8UC) ; Liraglutide (839I73S42A) ; Exenatide (9P1872D4OL) ; Vildagliptin (I6B4B2U96P) ; Adamantane (PJY633525U) ; Sitagliptin Phosphate (TS63EW8X6F) |
| Language | English |
| Publishing date | 2016-08-24 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 2711897-6 |
| ISSN | 2314-6753 ; 2314-6745 |
| ISSN (online) | 2314-6753 |
| ISSN | 2314-6745 |
| DOI | 10.1155/2016/6962574 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2022 Volume 22, Issue 1, Page(s) 920
Abstract: Background: Seeking pharmacist advice about minor ailments is a common practice among Iraqi patients because such advice is free and quick. Unfortunately, the assessment and management of minor ailments by Iraqi pharmacists were inappropriate. Therefore, ...
| Abstract | Background: Seeking pharmacist advice about minor ailments is a common practice among Iraqi patients because such advice is free and quick. Unfortunately, the assessment and management of minor ailments by Iraqi pharmacists were inappropriate. Therefore, this study aimed to develop a model for a mobile application that can assist community pharmacists in the diagnosis and management of minor ailments. Methods: The scientific content of the application was based on the information in the symptoms in the pharmacy and British National Formulary books. The design and content of the application were approved by two experts. Thereafter, the application was built for Android mobiles using flutter technology and dart language. A pre-post pilot study was conducted to assess outcomes associated with use of the application, including user acceptance and appropriateness of clinical recommendations. Fifteen students from the College of Pharmacy/University of Baghdad who had an Android mobile participated in this study. Two different scenarios about diarrhea were used during the pilot study, in which the researcher acted as a patient (SP) and the participant student as a pharmacist. Results: After using the application, the number of questions asked by the participated student to the SP was significantly increased to about double. Additionally, providing the SP with appropriate non-pharmacological and pharmacological therapy along with optimum counseling and education were also significantly improved. All study participants agreed on the application's ease of use and ability to reduce diagnosis and medication errors. Conclusions: The implementation of the newly developed mobile application, diarrhea management step by step, was associated with improvements in assessment and recommended treatments for diarrhea cases with good acceptance by a pilot sample of pharmacy students at Baghdad University. |
|---|---|
| MeSH term(s) | Community Pharmacy Services ; Diarrhea ; Humans ; Mobile Applications ; Pharmacists/psychology ; Pilot Projects |
| Language | English |
| Publishing date | 2022-07-15 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 2050434-2 |
| ISSN | 1472-6963 ; 1472-6963 |
| ISSN (online) | 1472-6963 |
| ISSN | 1472-6963 |
| DOI | 10.1186/s12913-022-08292-9 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of education and health promotion
2021 Volume 10, Page(s) 357
Abstract: Background: Diabetes self-management (DSM) is the cornerstone in diabetes mellitus (DM) management. Unfortunately, the practice of DSM by Iraqi type 2 DM (T2DM) patients is poor that mainly resulted from their poor knowledge about the required DSM ... ...
| Abstract | Background: Diabetes self-management (DSM) is the cornerstone in diabetes mellitus (DM) management. Unfortunately, the practice of DSM by Iraqi type 2 DM (T2DM) patients is poor that mainly resulted from their poor knowledge about the required DSM behaviors. This lack of knowledge may be attributed to the lack of DSM education and support (DSMES) program in Iraq. Thus, this study was conducted with aim of developing and validating a culturally specific DSMES program for Iraqi T2DM patients. Materials and methods: The development and validation of the DSMES program was done according to the Hilda Taba model. Content validity of the program was done by a panel of 6 health-care experts in management of Iraqi DM patients. Face validity was confirmed by conducting a pilot study for six adults with uncontrolled T2DM at the National Diabetes Center, Baghdad, Iraq. Both the experts and patients were asked to evaluate the developed program in regard to its contents, design, and supporting material (booklet). The evaluation was done by filling in a questionnaire that based on a 5-point scale. Items with a score ≥4 by <70% of the experts and patients were subjected to revision and further assessment. Results: No total disagreement for any item was expressed by all participants (experts and patients). Content and face validity was ensured through obtaining a positive feedback from all participants at which all items about the program had scores of ≥4 by at least 75% of participants. Conclusion: The developed culturally based DSMES program is highly suitable for educating Iraqi T2DM patients. |
|---|---|
| Language | English |
| Publishing date | 2021-09-30 |
| Publishing country | India |
| Document type | Journal Article |
| ZDB-ID | 2715449-X |
| ISSN | 2319-6440 ; 2277-9531 |
| ISSN (online) | 2319-6440 |
| ISSN | 2277-9531 |
| DOI | 10.4103/jehp.jehp_311_21 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of pharmacy & bioallied sciences
2015 Volume 7, Issue 1, Page(s) 65–68
Abstract: Background: Pharmaceutical industries worldwide are heavily involved in aggressive drug promotions. Physician targeted promotion through medical representatives is one of the most common tactic for drug promotion by pharmaceutical drug companies. WHO ... ...
| Abstract | Background: Pharmaceutical industries worldwide are heavily involved in aggressive drug promotions. Physician targeted promotion through medical representatives is one of the most common tactic for drug promotion by pharmaceutical drug companies. WHO states that medical representatives to work in an ethical way should make available to prescribers and dispensers complete and unbiased information for each product discussed; therefore this study aimed to evaluate the ethics in the medical brochures of generic pharmaceutical companies that are given through medical representatives to physicians in Iraq. Materials and methods: An observational, cross-sectional study was conducted in Iraq - Baghdad from February to April 2014. Promotional drug brochures were collected mainly from pharmaceutical exhibition during attendance of medical conferences that were sponsored by generic pharmaceutical companies. Evaluation of each brochure was based primarily on WHO criteria for ethical medicinal drug promotion. The availability of emotional pictures in each brochure was also examined. Furthermore, references were checked to find their retrievability, source, and authenticity of presentations. Results: Most medical brochures were for antibiotics, and drugs for cardiovascular diseases. All brochures mention drug name, with its active ingredient and indication, but there is a significant absence for drug interaction, while drug side effects and contraindications if present were written in a small font. Emotional picture presented in 70% of brochures. Reference citation was present in 72% of brochures, however only 75% of references in these brochures were correct. Conclusions: The information that is provided in medical brochures is biased and mainly persuasive since it is mainly focusing on the positive aspect of drug therapy. |
|---|---|
| Language | English |
| Publishing date | 2015-02-09 |
| Publishing country | India |
| Document type | Journal Article |
| ZDB-ID | 2573569-X |
| ISSN | 0975-7406 ; 0976-4879 |
| ISSN (online) | 0975-7406 |
| ISSN | 0976-4879 |
| DOI | 10.4103/0975-7406.148781 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2015 Volume 2, Page(s) 2333794X15608716
Abstract: Breast-feeding is the best method of feeding infants. In some cases, formula milk can be a suitable alternative, so this study aimed to compare the safety and nutritional adequacy of commonly available formula milks in the Iraqi market. An observational ... ...
| Abstract | Breast-feeding is the best method of feeding infants. In some cases, formula milk can be a suitable alternative, so this study aimed to compare the safety and nutritional adequacy of commonly available formula milks in the Iraqi market. An observational study for the commonly available formula milks was conducted in the largest supermarkets of Baghdad, Iraq, during January-March 2015. The macronutrient and micronutrient contents as presented in the label of each type of formula milk was compared with the standard requirement of formula milk according to the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines. Dielac formula milk is the commonest formula milk in the Iraqi market, with the lowest price when compared with other formula milks. All infant formula milks (Similac, Guigoz, and S-26 Gold) except Dielac have the mandatory contents within the specified ranges, according to the ESPGHAN guidelines. Dielac lacks more than 1 of the major mandatory contents besides lacking all optional contents in its formula. Guigoz formula milk lacks the optional ingredients arachidonic acid, docosahexaenoic acid, and nucleotides. Similac milk was supplemented with a higher-than-specified level of nucleotides, and its l-carnitine contents were not declared. Only S26 Gold formula milk contained all mandatory and optional ingredients within the specified range, according to the ESPGHAN guidelines. In conclusion, no formula milk can resemble breast milk; however, S26 Gold formula milk is the most acceptable formula, and Dielac formula milk is the worst. Therefore, it is recommended that Dielac be withdrawn from the Iraqi market. |
|---|---|
| Language | English |
| Publishing date | 2015-10-06 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2785531-4 |
| ISSN | 2333-794X ; 2333-794X |
| ISSN (online) | 2333-794X |
| ISSN | 2333-794X |
| DOI | 10.1177/2333794X15608716 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.